Deciphera Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Deciphera Pharmaceuticals

03/05/2023 14:32

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of 60 cents​​ per share for the quarter ended in
March. The mean expectation of eleven analysts for the quarter
was for a loss of 59 cents per share.
    * Revenue rose 14.4% to $33.45 million from a year ago;
analysts
expected $35.80 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 60 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.5%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates 
    * Deciphera Pharmaceuticals Inc shares had fallen by 7.4%
this
quarter and lost 12.8% so far this year.
    * The company reported a quarterly loss of $49.61 million.
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
3 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.59          -0.60          Missed
 Dec. 31 2022      -0.56          -0.60          Missed
 Sep. 30 2022      -0.58          -0.55          Beat
 Jun. 30 2022      -0.66          -0.60          Beat